ClinicalTrials.Veeva

Menu

The Efficacy and Security of the Small Stitch Technique in Emergency Surgery (STCU)

F

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Status

Unknown

Conditions

Abdominal Wall Hernia
Evisceration; Operation Wound
Abdominal Wall Defect
Eventration

Treatments

Procedure: Monomax® 1 HR48
Procedure: Monomax® 2/0 HR26

Study type

Interventional

Funder types

Other

Identifiers

NCT03765060
SL-Stitch

Details and patient eligibility

About

This study evaluates the abdominal closure technique in emergency surgery. Half of participants will be perform the classic Large Stitch technique, while the other half will undergo the Small Stitch technique.

Full description

The closure of laparotomy is one of the most important challenges facing the surgeon.

The classic technique of wall closure is the Large Stitch technique that uses monofilament double-strand sutures with a SL/WL (Suture Lengh/Wound Lengh) 4:1 ratio, with a distance to the alba line and between each stitch of 1 cm.

Nowadays, the Small Stitch technique is accepted as the technique of choice for closure of laparotomies in programmed surgery. It is based on a very long-term monofilament absorbable synthetic suture of Poly-4-hydroxybutyrate (Monomax) 2/0 with HR (Half-circle Round body) 26 needle. Stitches should be given with a distance to the alba line of 0'5cm and 0'5 cm of separation between stitches.

There are very few studies about the role of Small Stitch technique in the field of Emergency Surgery where the increased morbidity of the patient and the higher rate of surgical wound infection can play a fundamental role, and could be improved with the use of new abdominal wall closure techniques.

Enrollment

105 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients over 18 years of age and who provide informed consent to participate in the study.
  2. Patients requiring an urgent midline laparotomy with a minimum size of 8 cm.

Exclusion criteria

  1. Prior midline laparotomy.
  2. Patients with BMI> 45 kg / m2
  3. Patients with ASA (American Society of Anesthesiologists)> IV.
  4. Patient with an advanced terminal illness with an expectation of life <1 year.
  5. Patients with abdominal aortic aneurysm.
  6. Patients with coagulopathy: patient previously diagnosed with von Willebrand disease, hemophilia or Immune thrombocytopenic purpura.
  7. Immunosuppressed patient: HIV patients in the AIDS phase, chronic corticosteroid or immunosuppressive treatment.
  8. Patients with collagen pathology: patient previously diagnosed with Marfan syndrome, Ehlers-Danlos syndrome, homocystinuria and scleroderma.
  9. Chemotherapeutic treatment 2 weeks before surgery.
  10. Radiotherapy treatment 6 weeks before surgery.
  11. Diffuse peritonitis with hemodynamic instability, defined by non-response to fluids prior to surgery or during the surgical process.
  12. Pregnant or potentially fertile women, breastfeeding, or intention to become pregnant, or those who do not wish to use effective contraception (hormonal contraceptives (implantation, patches, oral), and double barrier methods (any double combination of: IUD (intrauterine device), male or female prophylactics with spermicidal gel, diaphragm, contraceptive sponge, cervical cap).

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

105 participants in 2 patient groups

Small Stitch
Experimental group
Description:
Patients requiring an urgent emergency laparotomy. The Small Stitch closure technique will be perform using a Monomax® 2/0 HR26 (Half-circle Round body): * It will be use a very long-term monofilament absorbable synthetic suture of Poly-4-hydroxybutyrate (Monomax) 2/0 with HR 26 needle (Half-circle Round body). * In the technique should be given at least 2 points for each wound cm, with a distance to the alba line of 0'5cm and 0'5 cm of separation between stitches. The closure starts from both ends, ending in the middle of the laparotomy with an overlap of at least 2 cm. The ratio between the length of the suture and the length of the wound should be at least 4:1.
Treatment:
Procedure: Monomax® 2/0 HR26
Large Stitch
Active Comparator group
Description:
The intervention will be the classic large Stitch closure technique using a Monomax® 1 HR48 (Half-circle Round body). * It will be use a very long-term monofilament absorbable synthetic suture of Poly-4-hydroxybutyrate (Monomax) 1 with HR 48 needle (Half-circle Round body). * In the technique should be given 1 point for each wound cm, with a distance to the alba line of 1 cm and 1 cm of separation between stitches. The closure starts from both ends, ending in the middle of the laparotomy with an overlap of at least 2 cm. The ratio between the length of the suture and the length of the wound should be at least 4:1.
Treatment:
Procedure: Monomax® 1 HR48

Trial contacts and locations

1

Loading...

Central trial contact

Tamayo López María Jesús, PhD; Tallón Aguilar Luis, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems